In Brief ASTRO launches national radiopharmaceutical therapy training centers February 06, 2026Vol.52 No.05
In Brief Neuroendocrine Tumor Research Foundation names 13 grant recipients February 06, 2026Vol.52 No.05
In Brief University of York awarded £2.5 million to study blood cancers in the U.K. February 06, 2026Vol.52 No.05
Clinical Roundup NCCN updates guidelines recognizing MammaPrint to guide personalized anthracycline use in HR+/HER2- early‑stage breast cancer February 06, 2026Vol.52 No.05
Clinical Roundup Neoadjuvant pembrolizumab helps shrink tumors in patients with desmoplastic melanoma February 06, 2026Vol.52 No.05
Clinical Roundup Oxybutynin reduces hot flashes during prostate cancer treatment, randomized study finds February 06, 2026Vol.52 No.05
Clinical Roundup Oral cancer pain and opioid tolerance share underlying process, study finds February 06, 2026Vol.52 No.05
Clinical Roundup Researchers build best practice framework to boost racial and cultural diversity in biospecimen research February 06, 2026Vol.52 No.05
Clinical Roundup Researchers create blueprint for designing CD8 killer T cells to kill cancer cells February 06, 2026Vol.52 No.05
Drugs & Targets FDA issues a boxed warning for capecitabine and fluorouracil on risks associated with DPD deficiency February 06, 2026Vol.52 No.05
